AI Stock Finder
Loading...
Skip to main content
Model output · Signal date Oct. 14, 2026

Daily SignalsNeutral

2481 companies scored · 2026-10-14 run in progress: 3773 of ~5379 signals so far · Alpha · vs marketSwitch to Total · 30D 90D

Signal date 2026-10-14 Cut-offs from the 2026-10-13 run
Companies scored 2481 IC ≥ 0 · market cap ≥ $100M
Median forecast +0.26% Alpha · 90D
Long–short spread +3.95% Strong Buy minus Strong Sell, mean
Median IC 0.29 Spearman · 90D
Rating changes ▲ 55 ▼ 58 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

72 companies

Sorted by 90D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1 ELVNEnliven Therapeutics, Inc. Life Sciences 0.40 $2.9B Neutral +0.37% +0.49% ·
2 GNLXGENELUX Corp Life Sciences 0.32 $114M Neutral +0.38% +0.49% ·
3 AMRXAmneal Pharmaceuticals, Inc. Life Sciences 0.02 $6.2B Neutral +0.17% +0.48% ·
4 VNDAVanda Pharmaceuticals Inc. Life Sciences 0.38 $260M Neutral +0.23% +0.48% ·
5 NUVBNuvation Bio Inc. Life Sciences 0.35 $1.7B Neutral +0.37% +0.46% ·
6 TRLVTrulieve Cannabis Corp. Life Sciences 0.06 $1.9B Neutral +0.23% +0.46% ·
7 TRVITrevi Therapeutics, Inc. Life Sciences 0.31 $1.8B Neutral +0.23% +0.46% ·
8 VCELVericel Corp Life Sciences 0.27 $2.1B Neutral -0.10% +0.45% ·
9 GILDGILEAD SCIENCES, INC. Life Sciences 0.26 $183.4B Neutral +0.23% +0.41% ·
10 ELDNEledon Pharmaceuticals, Inc. Life Sciences 0.00 $190M Neutral +0.38% +0.40% ·
11 NERVMinerva Neurosciences, Inc. Life Sciences 0.14 $120M Neutral +0.45% +0.38% ·
12 IFRXInflaRx N.V. Life Sciences 0.22 $112M Neutral -0.12% +0.36% ·
13 IMTXImmatics N.V. Life Sciences 0.26 $916M Neutral +0.38% +0.35% ·
14 SGMTSagimet Biosciences Inc. Life Sciences 0.37 $496M Neutral +0.32% +0.35% ·
15 ANABANAPTYSBIO, INC Life Sciences 0.56 $1.3B Neutral -0.05% +0.33% ·
16 ROIVRoivant Sciences Ltd. Life Sciences 0.42 $24.1B Neutral +0.23% +0.32% ·
17 AMRNAMARIN CORP PLC\UK Life Sciences 0.14 $4.9B Neutral +0.37% +0.29% ·
18 PRAXPraxis Precision Medicines, Inc. Life Sciences 0.28 $6.8B Neutral +0.23% +0.28% ·
19 OMEROMEROS CORP Life Sciences 0.46 $1.4B Neutral -0.10% +0.26% ·
20 ALKSAlkermes plc. Life Sciences 0.32 $6.7B Neutral +0.20% +0.25% ·
21 IONSIONIS PHARMACEUTICALS INC Life Sciences 0.53 $7.0B Neutral +0.60% +0.25% ·
22 SIGASIGA TECHNOLOGIES INC Life Sciences 0.46 $221M Neutral +0.23% +0.21% ·
23 PRGOPERRIGO Co plc Life Sciences 0.56 $2.1B Neutral +0.23% +0.20% ·
24 ADXNAddex Therapeutics Ltd. Life Sciences 0.01 $445M Neutral +0.23% +0.19% ·
25 ELANElanco Animal Health Inc Life Sciences 0.23 $11.2B Neutral -0.11% +0.19% ·
26 DFTXDefinium Therapeutics, Inc. Life Sciences 0.29 $4.6B Neutral +0.37% +0.17% ·
27 CYTKCYTOKINETICS INC Life Sciences 0.20 $8.6B Neutral +0.06% +0.16% ·
28 ASMBASSEMBLY BIOSCIENCES, INC. Life Sciences 0.14 $414M Neutral +0.59% +0.15% ·
29 ABUSArbutus Biopharma Corp Life Sciences 0.03 $813M Neutral +0.16% +0.14% ·
30 AGENAGENUS INC Life Sciences 0.08 $313M Neutral +0.28% +0.14% ·
31 IMRXImmuneering Corp Life Sciences 0.12 $230M Neutral +0.37% +0.11% ·
32 MOLNMOLECULAR PARTNERS AG Life Sciences 0.03 $148M Neutral -0.10% +0.11% ·
33 PTCTPTC THERAPEUTICS, INC. Life Sciences 0.25 $5.0B Neutral +0.23% +0.07% ·
34 TEVATEVA PHARMACEUTICAL INDUSTRIES LTD Life Sciences 0.01 $48.1B Neutral -0.27% +0.07% ·
35 QDELQuidelOrtho Corp Life Sciences 0.20 $967M Neutral -0.10% +0.05% ·
36 SPRYARS Pharmaceuticals, Inc. Life Sciences 0.27 $403M Neutral +0.94% +0.05% ·
37 AVXLANAVEX LIFE SCIENCES CORP. Life Sciences 0.03 $137M Neutral +0.23% +0.03% ·
38 AGIOAGIOS PHARMACEUTICALS, INC. Life Sciences 0.02 $1.8B Neutral -0.10% +0.01% ·
39 ACHVACHIEVE LIFE SCIENCES, INC. Life Sciences 0.00 $720M Neutral +0.23% -0.01% ·
40 AMPHAmphastar Pharmaceuticals, Inc. Life Sciences 0.47 $1.1B Neutral -0.11% -0.02% ·
41 ARVNARVINAS, INC. Life Sciences 0.28 $447M Neutral +0.37% -0.02% ·
42 NAGENiagen Bioscience, Inc. Life Sciences 0.67 $204M Neutral +0.20% -0.02% ·
43 SANASana Biotechnology, Inc. Life Sciences 0.30 $721M Neutral +0.54% -0.02% ·
44 CLLSCellectis S.A. Life Sciences 0.13 $110M Neutral +1.34% -0.03% ·
45 QTTBQ32 Bio Inc. Life Sciences 0.17 $240M Neutral -0.17% -0.04% ·
46 QUREuniQure N.V. Life Sciences 0.37 $1.3B Neutral +0.23% -0.04% ·
47 XTLBXTL BIOPHARMACEUTICALS LTD Life Sciences 0.14 $1.9B Neutral +0.23% -0.05% ·
48 PCRXPacira BioSciences, Inc. Life Sciences 0.31 $1.4B Neutral +0.23% -0.06% ·
49 VTRSViatris Inc Life Sciences 0.36 $19.8B Neutral -0.04% -0.09% ·
50 PRTAPROTHENA CORP PUBLIC LTD CO Life Sciences 0.31 $429M Neutral +0.27% -0.11% ·
1–50 of 72 Previous Next
Since the previous run

Rating changes

▲ 55▼ 58
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.